7min chapter

The Readout Loud cover image

339: RFK Jr.'s confirmation hearings, MASH drugs, and a controversial obesity ad

The Readout Loud

CHAPTER

Advancements in MASH Treatment

This chapter explores the evolution of fatty liver disease terminology from NASH to MASH and discusses groundbreaking findings from Akiro Therapeutics regarding the potential reversal of cirrhosis in advanced MASH cases. It highlights the impact of GLP-1 medications and the newly approved drug ResDefra, emphasizing their implications for treatment options and clinical outcomes. The chapter concludes with insights into ongoing drug therapy developments targeting liver health and the importance of timely patient enrollment in clinical trials.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode